Study #2019-0780
Randomized Controlled Trial of Repeat vs. Single Quadratus Lumborum Block to Reduce Opioid Prescriptions After Open Resection of Retroperitoneal Sarcoma ("RESQU-SARC" Trial)
MD Anderson Study Status
Not Accepting
Treatment Agent
Liposomal Bupivacaine, Quadratus Lumborum Block
Description
This phase II trial studies how well a repeat or single liposomal bupivacaine injection (quadratus lumborum block) works in reducing opioid prescriptions after surgery in patients with retroperitoneal sarcoma. Liposomal bupivacaine is a numbing medication. Giving a second injection block may decrease dependency on opioid medications for pain relief after surgery and prevent long-term use and addiction.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Retroperitoneal Sarcoma
Study phase:
Phase II
Physician name:
Christopher Scally
Department:
Surgical Oncology
For general questions about clinical trials:
1-877-421-1842
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.